BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 16249217)

  • 1. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Childs L; Roesel S; Tohme RA
    Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for global elimination of hepatitis B: a modelling study.
    Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB
    Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current and future burden of hepatitis B in Switzerland: a modelling study.
    Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
    Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
    Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study.
    Xie J; Wang X; Wang X; Li J; Jie Y; Hao Y; Gu J
    Glob Health Res Policy; 2024 Jan; 9(1):5. PubMed ID: 38246986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.
    Boora S; Sharma V; Kaushik S; Bhupatiraju AV; Singh S; Kaushik S
    Braz J Microbiol; 2023 Jun; 54(2):679-689. PubMed ID: 37059940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on diagnosis, management, and prevention of hepatitis B virus infection.
    Mahoney FJ
    Clin Microbiol Rev; 1999 Apr; 12(2):351-66. PubMed ID: 10194463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of hepatitis B virus infection in Korea.
    Yim SY; Kim JH
    Korean J Intern Med; 2019 Sep; 34(5):945-953. PubMed ID: 30919608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of hepatitis B vaccination in the United States, 1999-2018.
    He WQ; Guo GN; Li C
    Hepatology; 2022 Jun; 75(6):1566-1578. PubMed ID: 34855999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary prevention of liver cancer caused by HBV.
    Blumberg BS
    Front Biosci (Schol Ed); 2010 Jan; 2(2):756-63. PubMed ID: 20036981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real-world data review.
    Wang C; Zhang S; Zhao J; Wang M; Lu QB; Liu B; Du J; Cui F
    J Med Virol; 2023 Nov; 95(11):e29241. PubMed ID: 38010806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030.
    Al-Busafi SA; Alwassief A
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis.
    Rezaei N; Asadi-Lari M; Sheidaei A; Khademi S; Gohari K; Delavari F; Delavari A; Abdolhamidi E; Chegini M; Rezaei N; Jamshidi H; Bahrami Taghanaki P; Hasan M; Yoosefi M; FarzadFar F
    PLoS One; 2019; 14(1):e0198449. PubMed ID: 30645598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden and economic impact of vaccine-preventable cancer mortality.
    Bencina G; Oliver E; Meiwald A; Hughes R; Morais E; Weston G; Sundström K
    J Med Econ; 2024 Apr; 27(sup2):9-19. PubMed ID: 38721643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Eradication of Hepatitis B Infection After an Outreach Immunization Program in the Waorani Population in the Ecuadorian Amazon.
    Quizhpe E; Ñauta G; Córdoba-Doña JA; Teran E
    Am J Trop Med Hyg; 2016 Sep; 95(3):670-3. PubMed ID: 27382082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
    Allison RD; Patel MK; Tohme RA
    Vaccine; 2017 Jul; 35(33):4094-4098. PubMed ID: 28668571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underestimation of liver-related mortality in the United States.
    Asrani SK; Larson JJ; Yawn B; Therneau TM; Kim WR
    Gastroenterology; 2013 Aug; 145(2):375-82.e1-2. PubMed ID: 23583430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
    Shattock AJ; Johnson HC; Sim SY; Carter A; Lambach P; Hutubessy RCW; Thompson KM; Badizadegan K; Lambert B; Ferrari MJ; Jit M; Fu H; Silal SP; Hounsell RA; White RG; Mosser JF; Gaythorpe KAM; Trotter CL; Lindstrand A; O'Brien KL; Bar-Zeev N
    Lancet; 2024 May; 403(10441):2307-2316. PubMed ID: 38705159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV Vaccines: Advances and Development.
    Mahmood F; Xu R; Awan MUN; Song Y; Han Q; Xia X; Wei J; Xu J; Peng J; Zhang J
    Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.